pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 43 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
HLK-0006
Anaphylaxis
Pharmacin BV
1 catalysts
Phase 1
ABBV-547
Psoriasis
$ABBVAbbVie Inc.
0 catalysts
Phase 1
ACE-1334
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
0 catalysts
Phase 1
← prev
page 1 of 2
next →
131
Pain89
Neurology1
ACT-101
Myasthenia Gravis
Alpha Cancer Technologies Inc
0 catalysts
Phase 1
ALLO-329
Lupus Nephritis
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Phase 1
ART-26.12
Chemotherapy Induced Peripheral Neuropathy
$ARTLARTELO BIOSCIENCES, INC.
0 catalysts
Phase 1
ASC-50
Plaque Psoriasis (Psoriasis Vulgaris)
Ascletis Pharma Inc
0 catalysts
Phase 1
ASC-930
Graft Versus Host Disease (GVHD)
ASC Therapeutics Inc
0 catalysts
Phase 1
AUR-200
Systemic Lupus Erythematosus
$AUPHAurinia Pharmaceuticals Inc.
0 catalysts
Phase 1
BIIB-142
Lupus Nephritis
$BIIBBIOGEN INC.
0 catalysts
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
0 catalysts
Phase 1
CAN-10
Hidradenitis Suppurativa
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 1
CLN-978
Systemic Lupus Erythematosus
$CGEMCullinan Therapeutics, Inc.
0 catalysts
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
0 catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 1
HNC-1058
Idiopathic Pulmonary Fibrosis
Guangzhou Henovcom Bioscience Co Ltd
0 catalysts
Phase 1
IA-14069
Rheumatoid Arthritis
iLab Co Ltd
0 catalysts
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
0 catalysts
Phase 1
KINE-101A
Rheumatoid Arthritis
Kine Sciences
0 catalysts
Phase 1
LPXTI-641
Psoriatic Arthritis
Lapix Therapeutics Inc
0 catalysts
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVSNOVARTIS AG
0 catalysts
Phase 1
MRT-8102
Inflammation
$GLUEMonte Rosa Therapeutics, Inc.
0 catalysts
Phase 1
MuSK-CAART
Myasthenia Gravis
$CABACabaletta Bio, Inc.
0 catalysts
Phase 1
NIM-1324
Rheumatoid Arthritis
NImmune Biopharma Inc
0 catalysts
Phase 1
R-2487
Rheumatoid Arthritis
Rise Therapeutics LLC
0 catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0 catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 1
SAL-0119
Rheumatoid Arthritis
Shenzhen Salubris Pharmaceuticals Co Ltd
0 catalysts
Phase 1
SB-414
Atopic Dermatitis (Atopic Eczema)
$PTHSPelthos Therapeutics Inc.
0 catalysts